Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma

  1. Miguel, A.
  2. Sendra, L.
  3. Noé, V.
  4. Ciudad, C.J.
  5. Dasí, F.
  6. Hervas, D.
  7. Herrero, M.J.
  8. Aliño, S.F.
Journal:
OncoTargets and Therapy

ISSN: 1178-6930

Year of publication: 2017

Volume: 10

Pages: 503-514

Type: Article

DOI: 10.2147/OTT.S104393 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus